Kerry Wentworth sold $379K of NUVB stock

Kerry Wentworth, Chief Regulatory Officer of Nuvation Bio Inc. (NUVB), sold 63,000 shares of NUVB stock worth $379K, per an SEC Form 4 filed Jun 24, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 23, 2026, 1 day before it was made public.

NUVB has moved -33.9% since the trade date, from $6.04 to $4.00 (Nov 13, 2026 close).